These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3718915)

  • 21. Patterns of visual loss in untreated sickle cell retinopathy.
    Moriarty BJ; Acheson RW; Condon PI; Serjeant GR
    Eye (Lond); 1988; 2 ( Pt 3)():330-5. PubMed ID: 3402630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iris Atrophy in Sickle Cell Disease.
    Di Meglio L; Scott A
    N Engl J Med; 2022 Apr; 386(17):1646. PubMed ID: 35476653
    [No Abstract]   [Full Text] [Related]  

  • 23. Ocular findings in sickle cell-haemoglobin O Arab disease.
    Condon PI; Serjeant GR
    Br J Ophthalmol; 1979 Dec; 63(12):839-41. PubMed ID: 526465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New classification of peripheral retinal vascular changes in sickle cell disease.
    Penman AD; Talbot JF; Chuang EL; Thomas P; Serjeant GR; Bird AC
    Br J Ophthalmol; 1994 Sep; 78(9):681-9. PubMed ID: 7947547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryotherapy of proliferative sickle retinopathy, II: triple freeze-thaw cycle.
    Goldbaum MH; Fletcher RC; Jampol LM; Goldberg MF
    Br J Ophthalmol; 1979 Feb; 63(2):97-101. PubMed ID: 427076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sickle-cell retinopathy: Retrospective study of 730 patients followed in a referral center].
    Leveziel N; Lalloum F; Bastuji-Garin S; Binaghi M; Bachir D; Galacteros F; Souied E
    J Fr Ophtalmol; 2012 May; 35(5):343-7. PubMed ID: 22472104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epiretinal membranes in sickle cell disease.
    Moriarty BJ; Acheson RW; Serjeant GR
    Br J Ophthalmol; 1987 Jun; 71(6):466-9. PubMed ID: 3620428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive bilateral essential iris atrophy.
    Kaiser-Kupfer M; Kuwabara T; Kupfer C
    Am J Ophthalmol; 1977 Mar; 83(3):340-6. PubMed ID: 848538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behaviour of untreated proliferative sickle retinopathy.
    Condon PI; Serjeant GR
    Br J Ophthalmol; 1980 Jun; 64(6):404-11. PubMed ID: 7387965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sickle cell retinopathy: A literature review.
    Ribeiro MVMR; Jucá JVO; Alves ALCDS; Ferreira CVO; Barbosa FT; Ribeiro ÊAN
    Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1100-1103. PubMed ID: 29489976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vision-threatening eye manifestations in patients with sickle cell disease on Curaçao].
    van Meurs JC
    Ned Tijdschr Geneeskd; 1990 Sep; 134(37):1800-2. PubMed ID: 1699139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence and risk factors for sickle retinopathy in a sub-Saharan comprehensive Sickle Cell Center].
    Dembélé AK; Toure BA; Sarro YS; Guindo A; Fané B; Offredo L; Kené S; Conaré I; Tessougué O; Traoré Y; Badiaga Y; Sidibé MB; Diabaté D; Coulibaly M; Kanta M; Ranque B; Diallo DA
    Rev Med Interne; 2017 Sep; 38(9):572-577. PubMed ID: 28237127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of sickle cell retinopathy.
    Siegel D
    J Am Optom Assoc; 1988 Nov; 59(11):885-8. PubMed ID: 3230242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Macular Vascular Abnormalities Identified by Optical Coherence Tomography Angiography in Sickle Cell Disease.
    Han IC; Tadarati M; Pacheco KD; Scott AW
    Am J Ophthalmol; 2017 May; 177():90-99. PubMed ID: 28212878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood rheology and proliferative retinopathy in homozygous sickle cell disease.
    Serjeant BE; Mason KP; Acheson RW; Maude GH; Stuart J; Serjeant GR
    Br J Ophthalmol; 1986 Jul; 70(7):522-5. PubMed ID: 2424491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathology of sickle cell retinopathy.
    Romayanada N; Goldberg MF; Green WR
    Trans Am Acad Ophthalmol Otolaryngol; 1973; 77(5):OP652-76. PubMed ID: 4784908
    [No Abstract]   [Full Text] [Related]  

  • 37. Haematological factors associated with proliferative retinopathy in homozygous sickle cell disease.
    Hayes RJ; Condon PI; Serjeant GR
    Br J Ophthalmol; 1981 Jan; 65(1):29-35. PubMed ID: 6160870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A contribution on the clinical pictures, fluorescence angiography and histology oe essential progressive iris atrophy (author's transl)].
    Sautter H; Demeler U
    Klin Monbl Augenheilkd; 1977 Apr; 170(4):592-601. PubMed ID: 886801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiology and prognostic factors for sickle cell retinopathy in Ouagadougou (Burkina Faso)].
    Diallo JW; Sanfo O; Blot I; Meda N; Sawadogo P; Ouedraogo A; Simporé J
    J Fr Ophtalmol; 2009 Sep; 32(7):496-500. PubMed ID: 19520457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular manifestations of sickle cell disease at the Korle-bu Hospital, Accra, Ghana.
    Osafo-Kwaako A; Kimani K; Ilako D; Akafo S; Ekem I; Rodrigues O; Enweronu-Laryea C; Nentwich MM
    Eur J Ophthalmol; 2011; 21(4):484-9. PubMed ID: 21058274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.